Enrico Orvieto - Publications

Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian project.

Journal: Pathologica

Published: July 31, 2025

Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial.

Journal: ESMO open

Published: July 17, 2025

Patient safety in AI-powered diagnostic pathology.

Journal: Journal of clinical pathology

Published: April 23, 2025

Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial.

Journal: JAMA oncology

Published: February 13, 2025

"Artificial histology" in colonic Neoplasia: A critical approach.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 06, 2024

Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors.

Journal: Animals : an open access journal from MDPI

Published: January 25, 2023

Lockdown Measures Negatively Impacted Cancer Care.

Journal: American journal of clinical pathology

Published: December 31, 2020

Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic.

Journal: American journal of clinical pathology

Published: September 30, 2020

Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats.

Journal: Veterinary pathology

Published: August 19, 2020

Postsurgical Pyoderma Gangrenosum in a Breast Cancer Patient: A Case Report and Literature Review.

Journal: Case reports in oncology

Published: June 26, 2020

PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 05, 2020

Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 28, 2020